FDA Approved: REBLOZYL — Original Application (Celgene Corporation)

View source ↗

Summary

The FDA approved the original application for Reblozyl (luspatercept) from Celgene. This adds a new biologic for adults with transfusion-dependent anemia due to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Myelodysplastic Syndrome with Ring Sideroblasts

Drugs mentioned

• REBLOZYL (LUSPATERCEPT)

Snippet

ORIG AP for REBLOZYL (LUSPATERCEPT)